BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20113367)

  • 1. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
    Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
    Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner.
    Coppieters K; Van Beneden K; Jacques P; Dewint P; Vervloet A; Vander Cruyssen B; Van Calenbergh S; Chen G; Franck RW; Verbruggen G; Deforce D; Matthys P; Tsuji M; Rottiers P; Elewaut D
    J Immunol; 2007 Aug; 179(4):2300-9. PubMed ID: 17675491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonist.
    Walker KM; Rytelewski M; Mazzuca DM; Meilleur SA; Mannik LA; Yue D; Brintnell WC; Welch I; Cairns E; Haeryfar SM
    Immunol Cell Biol; 2012 Jul; 90(6):630-9. PubMed ID: 21912419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
    Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
    Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
    Yoshiga Y; Goto D; Segawa S; Horikoshi M; Hayashi T; Matsumoto I; Ito S; Taniguchi M; Sumida T
    Clin Exp Immunol; 2011 May; 164(2):236-47. PubMed ID: 21391989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis.
    Veenbergen S; Bennink MB; Affandi AJ; Bessis N; Biton J; Arntz OJ; van den Berg WB; van de Loo FA
    Ann Rheum Dis; 2011 Dec; 70(12):2167-75. PubMed ID: 21873688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
    Wang Y; Sedimbi SK; Löfbom L; Besra GS; Porcelli SA; Cardell SL
    Front Immunol; 2019; 10():352. PubMed ID: 30881361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ.
    Sakurai T; Inamine A; Iinuma T; Funakoshi U; Yonekura S; Sakurai D; Hanazawa T; Nakayama T; Ishii Y; Okamoto Y
    Clin Exp Immunol; 2014 Oct; 178(1):65-74. PubMed ID: 24943738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
    Oleinika K; Rosser EC; Matei DE; Nistala K; Bosma A; Drozdov I; Mauri C
    Nat Commun; 2018 Feb; 9(1):684. PubMed ID: 29449556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice.
    Hoya M; Nagamatsu T; Fujii T; Schust DJ; Oda H; Akiba N; Iriyama T; Kawana K; Osuga Y; Fujii T
    Am J Reprod Immunol; 2018 Mar; 79(3):. PubMed ID: 29363849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice.
    Zhou X; Hua X; Ding X; Bian Y; Wang X
    J Clin Immunol; 2011 Jun; 31(3):395-405. PubMed ID: 21305388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
    Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responses.
    Hogan AE; Corrigan MA; O'Reilly V; Gaoatswe G; O'Connell J; Doherty DG; Lynch L; O'Shea D
    Clin Immunol; 2011 Sep; 140(3):229-35. PubMed ID: 21684213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
    Lawson V
    Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
    Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
    BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma.
    Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
    J Biol Chem; 2019 Apr; 294(14):5438-5455. PubMed ID: 30745361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in silico approach for modelling T-helper polarizing iNKT cell agonists.
    De Spiegeleer A; Wynendaele E; Vandekerckhove M; Stalmans S; Boucart M; Van Den Noortgate N; Venken K; Van Calenbergh S; Aspeslagh S; Elewaut D
    PLoS One; 2014; 9(1):e87000. PubMed ID: 24498010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.